In our highly automated laboratories, experienced scientists design and execute a wide range of miniaturised, cost-effective assays tailored to your therapeutic needs. Our state-of-the-art equipment enables both large-scale screening of our small-molecule library, containing up to 3 million compounds, and focused screening of smaller sub-libraries. We specialise in ultra-HTS campaigns using biochemical, biophysical, mass spectrometry, cellular and phenotypic high-content assays.
learn more
Fragment screening is an efficient method for identifying new chemical matter quickly. We offer a broad range of biophysical and structural biology methods to identify initial binders from our proprietary library of 2,000 fragments, hand-selected by medicinal chemists. The 3D structure of fragment hits guides our expert medicinal and computational chemists in growing or linking approaches, often combined with HTS hits, to improve potency and selectivity.
learn more
We offer diverse virtual screening options to find new chemical starting points or expand existing hits. Our platform, supported by our life science database with over 500 million data points, integrates state-of-the-art machine learning-based predictive tools for rapid hit prioritisation. We provide tailored solutions to meet the specific needs of your drug discovery programs, helping ensure effective and efficient results.
learn more
Contact Us
Search